About Milton Point Partners
Milton Point Partners is a boutique investment bank that takes advantage of shifting market dynamics to establish a niche presence in the private capital markets space. We specialize in connecting life science innovators with sophisticated investors who understand the unique journey from lab to market.
While larger banks focus on later-stage opportunities, we provide the personalized attention and industry expertise that early-stage healthcare companies need to secure transformative capital. We cover Pre-Seed to Series C rounds across 4 healthcare sub-sectors.
Our Value Proposition
- Financial Clarity: Full visibility into company financials with milestone-aligned valuation
- Investor Access: Deep relationships with funds focused on life science opportunities
- Strategic Guidance: Business development advisory for growth-stage challenges
- Industry Expertise: Decades of combined pharma and investment banking experience
Our Services
Private Capital Raising
Strategic capital solutions from seed through Series C, connecting early-stage life science companies with investors who understand healthcare innovation. Services include Seed & Series A-C, Private Placements, and Equity Structuring.
Business Development Advisory
Go-to-market strategy and growth advisory for companies navigating the complex healthcare landscape, leveraging our deep pipeline experience. Services include Market Entry Strategy, Partnership Development, and Growth Planning.
M&A Advisory
Strategic transaction support for later-stage milestones, helping life science companies execute successful exits and strategic combinations. Services include Buy-Side Advisory, Sell-Side Advisory, and Transaction Support.
Investor Identification
Relationships with fund managers who have increased exposure to private markets, protecting early-stage companies from excessive dilution. Services include Investor Mapping, Targeted Outreach, and Relationship Management.
Healthcare Sub-Sectors
Pharmaceuticals
Supporting innovative pharmaceutical companies developing novel therapeutics across multiple modalities and therapeutic areas.
Biotechnology
Partnering with biotech pioneers advancing cutting-edge science from discovery through clinical development.
Medical Devices
Funding the next generation of medical technology transforming diagnostics, monitoring, and treatment delivery.
Digital Health
Enabling digital innovation in healthcare through software, AI, and connected health solutions.
Our Team
Our team structure is designed to address all the critical parts of a capital raise, positioning us to help clients get the necessary capital to reach their next developmental phase.
Nitish Mittal, PhD — Understanding the Science
10+ years in life sciences focusing on neuropharmacology, oncology, and evolving therapeutic areas. 7+ years at ZS Associates. HBS PLD alum, PhD from University of Texas, BS from UCLA.
Adam Blyer — Valuation & Equity Structuring
10+ years including Deloitte and McKinsey. Expert in company valuations across all lifecycle stages and equity dilution strategy. BBA and Masters in Professional Accounting from Emory University.
Sam Jackson — Targeting the Market
10+ years across private banking, investment banking, and consulting. Cultivated relationships with hundreds of buy-side investors focused on life sciences. BA from Wheaton College, MBA from University of Virginia.
Contact Us
Whether you're preparing for your next funding round or exploring strategic options, we'd love to learn about your company and how we might help.
Email: info@miltonpointpartners.com
Location: New York, NY